Argutus Medical is a world leader in developing and manufacturing specialised organ injury assays. Argutus Medical primarily focuses on the development of enzyme immunoassay (ELISA) tests and lateral flow rapid test devices for detection of acute kidney injury (AKI) and acute liver injury. Argutus also manufactures an assay for Genotoxicity called OxyDNA.Argutus Medical was previously part of Biotrin International before branching out in 2008. In 2010 Argutus Medical was acquired by EKF Diagnostics Holdings plc, a rapidly growing global health care company. This acquisition has allowed Argutus Medical to continue to focus on biomarker discovery and development of novel biomarker assays.
Here are the company performance indicators
Your indicators are as low as they can get. Update your data and add content (text, logo, keywords) to increase your visibility and ranking.